CBS – Once-A-Week Drug For Diabetes Under FDA Consideration

The FDA is considering a medicine that would be a weekly shot. And it’s not insulin. It’s a hormone called albiglutide — to be marketed by Glaxo Smith Kline as Eperzan. Read more



from DiabetesNews http://ift.tt/1o3jnXB